KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Capital Expenditures (2016 - 2026)

National Health Investors filings provide 18 years of Capital Expenditures readings, the most recent being $105.5 million for Q1 2026.

  • On a quarterly basis, Capital Expenditures rose 41.63% to $105.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $305.1 million, a 43.49% increase, with the full-year FY2025 number at $274.1 million, up 98.42% from a year prior.
  • Capital Expenditures hit $105.5 million in Q1 2026 for National Health Investors, down from $143.1 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $143.1 million in Q4 2025 to a low of -$4.3 million in Q3 2022.
  • Median Capital Expenditures over the past 5 years was $23.2 million (2023), compared with a mean of $46.3 million.
  • The widest YoY moves for Capital Expenditures: up 8607.14% in 2022, down 109.3% in 2022.
  • National Health Investors' Capital Expenditures stood at -$528000.0 in 2022, then surged by 7034.47% to $36.6 million in 2023, then skyrocketed by 250.31% to $128.3 million in 2024, then grew by 11.56% to $143.1 million in 2025, then dropped by 26.28% to $105.5 million in 2026.
  • The last three reported values for Capital Expenditures were $105.5 million (Q1 2026), $143.1 million (Q4 2025), and $56.5 million (Q2 2025) per Business Quant data.